The Center for Health Communication is a joint academic center bringing together researchers and experts across broad areas of health communication so they can collaborate, share ideas and innovations, and advance their scholarship and its impact to the highest possible level. The Center can be a resource for teams pursuing SBIR & STTR grants and other external funding opportunities, especially in regards to health interventions such as mobile apps, e-health applications, etc.

Global Innovation Lab partners with governments, universities and industries to train and support entrepreneurs in their communities to overcome local challenges, create jobs, and drive sustainable economic development. Services provided include support in developing incubator management, technology transfer, commercialization, and ecosystem development.

The LaunchPad at UT Austin is a resource hub that helps all undergraduate and graduate students explore entrepreneurship at UT. We help students identify where they are in their entrepreneurial journey – Explore, Ideate, Create, or Scale – then educate and connect them to resources across campus and in Austin. LaunchPad resources include events, coworking space, funding, bootcamps, accelerators, and other programs. We are a proud member of the global Blackstone LaunchPad Network of 46+ campuses.

Interested in SBIR/STTR funding but not sure where to begin? Writing your proposal and looking for expert guidance? On-demand webinars about SBIR/STTR programs and agency proposal requirements are available to the UT Austin community at no cost through our collaboration with BBC Entrepreneurial Training & Consulting.

The Texas Global Health Security Innovation Consortium (TEXGHS) connects academic, public- and private-sector partners to support companies working towards pandemic preparedness and response in Texas. TEXGHS is developing a health security innovation ecosystem that supports innovators and innovations fighting COVID-19 and future pandemics. UT Austin entrepreneurs should contact TEXGHS when they are seeking to commercialize infectious disease-related innovations at any stage of development.